Literature DB >> 8939559

Antibiotic resistance: counting the cost.

B G Spratt1.   

Abstract

Acquisition of drug resistance should impose a cost on bacteria. Recent studies, however, suggest that natural selection acts to reduce, or eliminate, the growth disadvantage of resistant bacteria, making it difficult to reverse the high levels of antibiotic resistance currently found in hospitals and the community.

Mesh：

Substances：

Year:  1996        PMID： 8939559     DOI： 10.1016/s0960-9822(96)00700-2

Source DB:  PubMed          Journal:  Curr Biol        ISSN： 0960-9822            Impact factor:   10.834


  8 in total

1.  Fitness cost of chromosomal drug resistance-conferring mutations.

Authors:  Peter Sander; Burkhard Springer; Therdsak Prammananan; Antje Sturmfels; Martin Kappler; Michel Pletschette; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Frequency of bacteriocin resistance development and associated fitness costs in Listeria monocytogenes.

Authors:  A Gravesen; A-M Jydegaard Axelsen; J Mendes da Silva; T B Hansen; S Knøchel
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

3.  Combining mathematical models and statistical methods to understand and predict the dynamics of antibiotic-sensitive mutants in a population of resistant bacteria during experimental evolution.

Authors:  Leen De Gelder; José M Ponciano; Zaid Abdo; Paul Joyce; Larry J Forney; Eva M Top
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

Review 4.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

5.  Virulence of antibiotic-resistant Salmonella typhimurium.

Authors:  J Björkman; D Hughes; D I Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

Authors:  Francesca Meacci; Germano Orrù; Elisabetta Iona; Federico Giannoni; Claudio Piersimoni; Gianni Pozzi; Lanfranco Fattorini; Marco R Oggioni
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

7.  The role of clonal interference in the evolutionary dynamics of plasmid-host adaptation.

Authors:  Julie M Hughes; Brian K Lohman; Gail E Deckert; Eric P Nichols; Matt Settles; Zaid Abdo; Eva M Top
Journal:  MBio       Date:  2012-07-03       Impact factor: 7.867

Review 8.  Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis.

Authors:  Mashael Al-Saeedi; Sahal Al-Hajoj
Journal:  Infect Drug Resist       Date:  2017-10-13       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.